
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $4.4B | $4.7B | $4.8B | $4.6B | $4.5B | |
Revenue Growth (YoY) | -11.75% | 8.17% | 0.86% | -3.89% | -0.7% | |
Cost of Revenues | $2.3B | $2.4B | $2.5B | $2.3B | $2.2B | |
Gross Profit | $2.1B | $2.3B | $2.2B | $2.3B | $2.3B | |
Gross Profit Margin | 47.98% | 49.04% | 46.73% | 49.95% | 50.99% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.9B | $1.9B | $1.8B | $1.7B | $1.7B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.8B | $1.9B | $1.7B | $1.6B | $1.6B | |
Operating Income | $292.6M | $458.1M | $490.4M | $638.3M | $695.3M | |
Net Interest Expenses | $70.6M | $72.9M | $2.5M | $13.7M | $30.7M | |
EBT. Incl. Unusual Items | $487.7M | $243.5M | $400M | $613.5M | $651.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $64.2M | -$1.4M | $97.8M | $140.6M | $95.9M | |
Net Income to Company | $487.7M | $243.5M | $400M | $613.5M | $651.8M | |
Minority Interest in Earnings | -- | -$1.4M | -$2.5M | -$2.5M | -$1.3M | |
Net Income to Common Excl Extra Items | $423.5M | $243.5M | $299.7M | $470.4M | $554.7M | |
Basic EPS (Cont. Ops) | $0.56 | $0.32 | $0.41 | $0.66 | $0.82 | |
Diluted EPS (Cont. Ops) | $0.56 | $0.32 | $0.40 | $0.66 | $0.81 | |
Weighted Average Basic Share | $755.4M | $754.1M | $738.1M | $711.5M | $673M | |
Weighted Average Diluted Share | $755.4M | $759.1M | $742M | $717.3M | $684M | |
EBITDA | $1.4B | $1.3B | $1.3B | $1.4B | $1.4B | |
EBIT | $589.1M | $337.1M | $485.4M | $689.4M | $752.8M | |
Revenue (Reported) | $4.4B | $4.7B | $4.8B | $4.6B | $4.5B | |
Operating Income (Reported) | $292.6M | $458.1M | $490.4M | $638.3M | $695.3M | |
Operating Income (Adjusted) | $589.1M | $337.1M | $485.4M | $689.4M | $752.8M |
Period Ending | 2009-12-31 | 2010-12-31 | 2011-12-31 | 2012-12-31 | 2013-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | 131.43% | -26.88% | 5.28% | 22.66% | 2.6% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $4.4B | $4.7B | $4.7B | $4.6B | $4.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.3B | $2.4B | $2.5B | $2.3B | $2.2B | |
Gross Profit | $2.1B | $2.3B | $2.2B | $2.3B | $2.3B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.8B | $1.9B | $1.7B | $1.6B | $1.6B | |
Operating Income | $306.9M | $449.6M | $476.6M | $639.3M | $692.4M | |
Net Interest Expenses | $70.7M | $72.7M | $1.1M | $13.7M | $30.5M | |
EBT. Incl. Unusual Items | $498.6M | $238.8M | $394.8M | $614.6M | $649M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $67M | -$2M | $96.9M | $140.8M | $95M | |
Net Income to Company | $497.6M | $238.8M | $394.8M | $614.6M | $649M | |
Minority Interest in Earnings | -- | -$1.4M | -$2.4M | -$2.5M | -$1.3M | |
Net Income to Common Excl Extra Items | $431.6M | $239.4M | $295.6M | $471.3M | $552.7M | |
Basic EPS (Cont. Ops) | $0.57 | $0.32 | $0.40 | $0.66 | $0.82 | |
Diluted EPS (Cont. Ops) | $0.57 | $0.32 | $0.40 | $0.66 | $0.81 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.4B | $1.3B | $1.2B | $1.4B | $1.4B | |
EBIT | $600.7M | $331.8M | $476.5M | $690.5M | $749.7M | |
Revenue (Reported) | $4.4B | $4.7B | $4.7B | $4.6B | $4.5B | |
Operating Income (Reported) | $306.9M | $449.6M | $476.6M | $639.3M | $692.4M | |
Operating Income (Adjusted) | $600.7M | $331.8M | $476.5M | $690.5M | $749.7M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.5B | $1.3B | $675.3M | $397.5M | $681.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.1B | $1.2B | $997.2M | $884.1M | $759.1M | |
Inventory | $175.8M | $132.3M | $127.1M | $115.9M | $92.9M | |
Prepaid Expenses | $260.3M | $269.9M | $243.3M | $298.1M | -- | |
Other Current Assets | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
Total Current Assets | $4.6B | $4.3B | $3.4B | $3.1B | $3.4B | |
Property Plant And Equipment | $701.9M | $494M | $302.6M | $276.4M | $271M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $2.9B | $2.9B | $3B | $3.1B | $3.1B | |
Other Intangibles | $883.1M | $842.2M | $843.5M | $837M | $739.1M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $10.2B | $9.9B | $8.9B | $8.6B | $8.6B | |
Accounts Payable | $463.4M | $473.7M | $421.1M | $403.8M | $342.6M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $99.5M | $91.8M | $85.9M | $81.5M | $81.6M | |
Other Current Liabilities | $293M | $112M | $64.1M | $39.5M | $33.9M | |
Total Current Liabilities | $2.2B | $2.1B | $1.8B | $1.8B | $1.9B | |
Long-Term Debt | $1.1B | $917.8M | $738.2M | $778.4M | $884.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.5B | $4.1B | $3.5B | $3.5B | $3.6B | |
Common Stock | $256.2M | $255.1M | $216.6M | $221.7M | $208.3M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $5.6B | $5.8B | $5.3B | $5.1B | $5.1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $12.3M | $13.5M | $15.7M | $17.8M | $18.8M | |
Total Equity | $5.6B | $5.8B | $5.3B | $5.1B | $5.1B | |
Total Liabilities and Equity | $10.2B | $9.9B | $8.9B | $8.6B | $8.6B | |
Cash and Short Terms | $1.5B | $1.3B | $675.3M | $397.5M | $681.4M | |
Total Debt | $1.3B | $1B | $756.4M | $782.2M | $1.2B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.5B | $1.3B | $675.3M | $397.5M | $681.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.1B | $1.2B | $997.2M | $884.1M | $759.1M | |
Inventory | $175.8M | $132.3M | $127.1M | $115.9M | $92.9M | |
Prepaid Expenses | $260.3M | $269.9M | $243.3M | $298.1M | -- | |
Other Current Assets | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
Total Current Assets | $4.6B | $4.3B | $3.4B | $3.1B | $3.4B | |
Property Plant And Equipment | $701.9M | $494M | $302.6M | $276.4M | $271M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $2.9B | $2.9B | $3B | $3.1B | $3.1B | |
Other Intangibles | $883.1M | $842.2M | $843.5M | $837M | $739.1M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $10.2B | $9.9B | $8.9B | $8.6B | $8.6B | |
Accounts Payable | $463.4M | $473.7M | $421.1M | $403.8M | $342.6M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $99.5M | $91.8M | $85.9M | $81.5M | $81.6M | |
Other Current Liabilities | $293M | $112M | $64.1M | $39.5M | $33.9M | |
Total Current Liabilities | $2.2B | $2.1B | $1.8B | $1.8B | $1.9B | |
Long-Term Debt | $1.1B | $917.8M | $738.2M | $778.4M | $884.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.5B | $4.1B | $3.5B | $3.5B | $3.6B | |
Common Stock | $256.2M | $255.1M | $216.6M | $221.7M | $208.3M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $12.3M | $13.5M | $15.7M | $17.8M | $18.8M | |
Total Equity | $5.6B | $5.8B | $5.3B | $5.1B | $5.1B | |
Total Liabilities and Equity | $10.2B | $9.9B | $8.9B | $8.6B | $8.6B | |
Cash and Short Terms | $1.5B | $1.3B | $675.3M | $397.5M | $681.4M | |
Total Debt | $1.3B | $1B | $756.4M | $782.2M | $1.2B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $487.7M | $243.5M | $400M | $613.5M | $651.8M | |
Depreciation & Amoritzation | $766.2M | $945.1M | $765.3M | $675.7M | $672.2M | |
Stock-Based Compensation | $37.2M | $38.5M | $43.3M | $49.8M | $56.2M | |
Change in Accounts Receivable | -$1.3M | -$97.7M | $40.9M | -$29.9M | $40.9M | |
Change in Inventories | $44.9M | $30.3M | -$42.1M | $11.2M | $19.2M | |
Cash From Operations | $499.3M | $448.5M | $447M | $653.3M | $801.3M | |
Capital Expenditures | $172M | $242.1M | $182M | $156.8M | $158.5M | |
Cash Acquisitions | $802.2M | $24.8M | $123.8M | -$266.3M | -$58.8M | |
Cash From Investing | $758.5M | -$110.1M | $16.1M | -$374.5M | -$167.4M | |
Dividends Paid (Ex Special Dividend) | -$187.4M | -$205M | -$193.2M | -$191.6M | -$199.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $444.1M | -- | -- | $354.6M | $1.6B | |
Long-Term Debt Repaid | -$295.2M | -$229.7M | -$211.8M | -$354.6M | -$1.2B | |
Repurchase of Common Stock | -$233.6M | -$22M | -$483M | -$275M | -$457.5M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$383.8M | -$569.6M | -$995.6M | -$559.9M | -$308M | |
Beginning Cash (CF) | $557M | $1.5B | $1.2B | $675.7M | $394.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $874M | -$231.1M | -$532.5M | -$281.2M | $325.9M | |
Ending Cash (CF) | $1.4B | $1.3B | $672.4M | $384.5M | $694M | |
Levered Free Cash Flow | $327.3M | $206.4M | $265M | $496.5M | $642.9M |
Period Ending | 2004-06-30 | 2005-06-30 | 2006-06-30 | 2007-06-30 | 2008-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $16.3M | $641.2M | $36.6M | -- | -$96.6M | |
Depreciation & Amoritzation | -- | $220.7M | -- | -- | $163.7M | |
Stock-Based Compensation | -- | -- | -- | -- | $31.5M | |
Change in Accounts Receivable | -- | -$57M | -- | -- | -$96.6M | |
Change in Inventories | -- | -$129.5M | -- | -- | -$207M | |
Cash From Operations | $16.3M | -$259M | -$429.6M | -- | -$467.3M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -$36.1M | $721M | -$495.9M | -- | -$493M | |
Cash From Investing | -$70.5M | $491M | -$519.6M | -- | -$554.1M | |
Dividends Paid (Ex Special Dividend) | -$215M | -$232.1M | -$248.4M | -- | -$351M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $847.3M | -- | -- | -- | $1.3B | |
Long-Term Debt Repaid | -$77.7M | -- | -- | -- | -$199.2M | |
Repurchase of Common Stock | -$3.6M | -$20.7M | -$49.5M | -- | -$39.4M | |
Other Financing Activities | $213.2M | $1M | -$20.8M | -- | $39.4M | |
Cash From Financing | $758.8M | $107.7M | $556.3M | -- | $761.1M | |
Beginning Cash (CF) | -- | $1B | $1.5B | -- | $970.1M | |
Foreign Exchange Rate Adjustment | -- | $42.5M | -$38.6M | -- | $29.6M | |
Additions / Reductions | $41.6M | $339.8M | -$392.9M | -- | -$260.3M | |
Ending Cash (CF) | $41.6M | $1.4B | $1.1B | -- | $739.4M | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $497.6M | $238.8M | $394.8M | $614.6M | $649M | |
Depreciation & Amoritzation | $774.6M | $942.5M | $748.2M | $676.9M | $668.5M | |
Stock-Based Compensation | $37.3M | $38.5M | $42.6M | $49.9M | $55.9M | |
Change in Accounts Receivable | -$9.3M | -$94.8M | $39.9M | -$30M | $41.6M | |
Change in Inventories | $46.3M | $29.5M | -$42.7M | $11.1M | $19.2M | |
Cash From Operations | $524.6M | $435.7M | $421.8M | $652.2M | $801.4M | |
Capital Expenditures | $170.6M | $240.7M | $178.3M | $157.1M | $157.7M | |
Cash Acquisitions | $778.4M | $23.4M | $108.1M | -$267.7M | -$58.1M | |
Cash From Investing | $733.9M | -$111.8M | $2.9M | -$376.2M | -$166.2M | |
Dividends Paid (Ex Special Dividend) | -$184.6M | -$205.9M | -$192.1M | -$192.3M | -$197.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $428.8M | -- | -- | $356.1M | $1.6B | |
Long-Term Debt Repaid | -$285.2M | -$233.4M | -$208.8M | -$354M | -$1.2B | |
Repurchase of Common Stock | -$226.2M | -$21.9M | -$472M | -$274.7M | -$452.5M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$378.8M | -$573.5M | -$979M | -$558.4M | -$309.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $861.2M | -$259M | -$574.2M | -$276.2M | $308M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $354M | $195M | $243.5M | $495.1M | $643.7M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.